Evaluating the Effectiveness of Prednisone, Azathioprine, and N-acetylcysteine in Patients With IPF
What is the purpose of this trial?
Idiopathic pulmonary fibrosis (IPF) is a long-term lung disease that affects an individual's ability to breathe. This study will evaluate the effectiveness of the antioxidant N-acetylcysteine (NAC), at preventing the loss of lung function in people with IPF.
- 35 Years - 85 Years
- Duke University
National Heart, Lung, and Blood Institute (NHLBI)
- October 2009
- Last Updated:
- May 19, 2014
- Study HIC#:
Clinicaltrials.gov ID: NCT00650091